Wilk Auslander’s Transborder Technology Team represents SamanTree Medical SA in CHF4.5 million Series A Round

January, 2015—Geneva—Wilk Auslander’s Transborder Technology Team in Geneva represented SamanTree Medical SA in its recent CHF4.5 million Series A Round.  The deal will enable SamanTree Medical to accelerate the development and commercialization of its advanced intra-operative digital pathology scanner for rapid and convenient assessment of cancer tissue during oncologic surgeries.

“We’re proud to have played a role in helping our client, SamanTree Medical, raise the funds to continue to develop its cutting-edge technologies,” said Karen A. Monroe, Partner in Geneva.  Pierre Ollivier, head of Wilk Auslander’s Transborder Technology Team added “Karen and Olga Larionova’s roles in this transaction are further demonstration of our Transborder Technology Team’s capability to execute sophisticated international financing transactions.”